(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ISORDIL

Did you know this trademark is already registered in Brazil?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Registro de marca em vigorType: WordOffice: Brazil

Quick snapshot

ISORDIL

ST13

BR500000003557804

Class

5

Filing

003557804

Registration

003557804

Progress at the INPI

  1. Filing10/27/61
  2. Publication
  3. Examination
  4. Allowance
  5. Grant04/25/67
  6. In force04/25/37

The registration was granted on 04/25/1967 and is in force until 04/25/2037, when it must be renewed.

Protection valid until:04/25/2037

AlertaMarcas

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 06/09/2026. We update with every new RPI gazette, published weekly.

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

INPI status

Registro de marca em vigor

Case type

Application and registration

Recorded events

8

Latest update

06/09/2026

Trademark type

Word

Nice classes

5

Filing date

10/27/1961

Registration date

04/25/1967

Expiration date

04/25/2037

Complete case details

Structured fields from the responsible authority and the official record.

Nature

De Produto

Responsible office

Brazil

Owner type

PESSOA JURÍDICA

Owner location

SP, BR

Holders and representatives

Holders

SIGMA PHARMA LTDA

Representatives

CARLOS NOGUEIRA ADVOGADOSVer perfil do escritório

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Produto farmacêutico indicado no tratamento das afecções cardio-vasculares

Publications

History of INPI decisions and trademark events.

8 publications found

IPAS270

Deferimento da petição

Protocolo: 800260111925 (12/05/2026) Petição (tipo): Prorrogação de registro de marca e expedição de certificado no prazo ordinário (374.5) Titular(es): EMS SIGMA PHARMA LTDA Procurador: Gabriel Alves De Jong

RPI 2892

06/09/2026

IPAS270

Deferimento da petição

Protocolo: 800160252917 (06/09/2016) Petição (tipo): Prorrogação de registro de marca e expedição de certificado no prazo ordinário (374.5) Titular: EMS SIGMA PHARMA LTDA Procurador: Patricia Aparecida Ferreira Esteves

RPI 2405

02/07/2017

990

CONCEDIDA A PRORROGACAO DO REGISTRO. O Certificado de prorrogacao de Registro estara a disposicao do Titular na Recepcao da Diretoria de Marcas, apos 60 (sessenta) dias a contar desta data. Podera, a pedido, ser remetido a qualquer Delegacia e/ou Representacao do INPI/MICT.

PRORROGADO CONFORME RESOLUÇÃO 123 DE 06/01/2006, PUBLICADA NA RPI 1829, DE 24/01/2006.

RPI 1910

08/14/2007

565

ANOTADA A TRANSFERENCIA.

CED. LABORATORIOS WYETH-WHITEHALL LTDA

RPI 1791

05/03/2005

565

ANOTADA A TRANSFERENCIA.

CED. LABORATORIOS WYETH-WHITEHALL LTDA( NOMES ALTERADOS)

RPI 1595

07/31/2001

565

ANOTADA A TRANSFERENCIA.

CED. AMERICAN HOME PRODUCTS CORPORATION

RPI 1547

08/29/2000

990

CONCEDIDA A PRORROGACAO DO REGISTRO. O Certificado de prorrogacao de Registro estara a disposicao do Titular na Recepcao da Diretoria de Marcas, apos 60 (sessenta) dias a contar desta data. Podera, a pedido, ser remetido a qualquer Delegacia e/ou Representacao do INPI/MICT.

*INT. DANNEMANN.

RPI 1393

08/12/1997

990

CONCEDIDA A PRORROGACAO DO REGISTRO. O Certificado de prorrogacao de Registro estara a disposicao do Titular na Recepcao da Diretoria de Marcas, apos 60 (sessenta) dias a contar desta data. Podera, a pedido, ser remetido a qualquer Delegacia e/ou Representacao do INPI/MICT.

RPI 883

09/22/1987

SIGMA PHARMA LTDA also protects technology and design at the INPI

1 patent application under the same owner.

Related trademarks

Similar trademarks

Continuous trademark protection

Get notified about every new filing that threatens ISORDIL or your mark.

Professional 24-month watch service: we monitor INPI for you and alert you in time to oppose — before conflicts become losses.